Application of protein lysate microarrays to molecular marker verification and quantification

Proteome Science

Volumn 3, Issue , 2005, Pages

  Ramaswamy, Anitha ^a   Lin, E ^a   Chen, Iou ^b   Mitra, Rahul ^c   Morrisett, Joel ^b   Coombes, Kevin ^a   Ju, Zhenlin ^a   Kapoor, Mini ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Spectral Genomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; BIOCHEMICAL MARKER; LIPOPROTEIN A; MOLECULAR MARKER; PROTEIN HYDROLYSATE;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; VALIDATION PROCESS;

ANIMALIA;

EID: 28044449746     PISSN: 14775956     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-3-9     Document Type: Article

References (37)

1. Sparre T, Christensen UB, Mose Larsen P, Fey SJ, Wrzesinski K, Roepstorff P, Mandrup-Poulsen T, Pociot F, Karlsen AE, Nerup J: IL-1beta induced protein changes in diabetes prone BB rat islets of Langerhans identified by proteome analysis. Diabetologia 2002, 45:1550-1561.
2. Hojlund K, Wrzesinski K, Larsen PM, Fey SJ, Roepstorff P, Handberg A, Dela F, Vinten J, McCormack JG, Reynet C, Beck-Nielsen H: Proteome analysis reveals phosphorylation of ATP synthase beta -subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 2003, 278:10436-10442.
3. Edvardsson U, von Lowenhielm HB, Panfilov O, Nystrom AC, Nilsson, F, Dahllof B: Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators. Proteomics 2003, 3:468-478.
4. Bernard KR, Jonscher KR, Resing KA, Ahn NG: Methods in functional proteomics: two-dimensional polyacrylamide gel electrophoresis with immobilized pH gradients, in-gel digestion and identification of proteins by mass spectrometry. Methods Mol Biol 2004, 250:263-282.
5. Ong SE, Foster U, Mann M: Mass spectrometric-based approaches in quantitative proteomics. Methods 2003, 29:124-130.
6. Bottari P, Aebersold R, Turecek F, Gelb MH: Design and synthesis of visible isotope-coded affinity tags for the absolute quantification of specific proteins in complex mixtures. Bioconjug Chem 2004, 15:380-388.
7. Toney JH, Ogawa A, Blair M, Park YW: A "mix and read" assay for insulin using fluorometric microvolume assay technology. Assay Drug Dev Technol 2003, 1:521-525.
8. Kakizawa H, Itoh M, Itoh Y, Imamura S, Ishiwata Y, Matsumoto T, Yamamoto K, Kato T, Ono Y, Nagata M, Hayakawa N, Suzuki A, Goto Y, Oda N: The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism 2004, 53:550-555.
9. Hernandez C, Lecube A, Castellanos JM, Segura RM, Garat M, Garcia-Arumi J, Simo R: Intravitreous leptin concentrations in patients with proliferative diabetic retinopathy. Retina 2004, 24:30-35.
10. Schena M, Heller RA, Theriault TP, Konrad K, Lachenmeier E, Davis RW: Microarrays: biotechnology's discovery platform for functional genomics. Trends Biotechnol 1998, 16:301-306.
11. Ferea TL, Brown PO: Observing the living genome. Curr Opin Genet Dev 1999, 9:715-722.
12. Brown PO, Botstein D: Exploring the new world of the genome with DNA microarrays. Nat Genet 1999, 21:33-37.
13. Ekins RP: Multi-analyte immunoassay. J Pharm Biomed Anal 1989, 7:155-168.
14. MacBeath G, Schreiber SL: Printing proteins as microarrays for high-throughput function determination. Science 2000, 289:1760-1763.
15. MacBeath G: Protein microarrays and proteomics. Nat Genet 2002, Suppl 32:526-532.
16. Cahill DJ, Nordhoff E: Protein arrays and their role in proteomics. Adv Biochem Eng Biotechnol 2003, 83:177-187.
17. Liotta, LA, Espina V, Mehta AI, Calvert V, Rosenblatt K, Geho D, Munson PJ, Young L, Wulfkuhle J, Petricoin EF 3rd: Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003, 3:317-325.
18. Petricoin EF, Liotta LA: Clinical applications of proteomics. J Nutr 2003, 133:2476S-2484S.
19. Angenendt, P, Glokler J, Murphy, D, Lehrach H, Cahill DJ: Toward optimized antibody microarrays: a comparison of current microarray support materials. Anal Biochem 2002, 309:253-260.
20. Angenendt P, Glokler J, Sobek J, Lehrach H, Cahill DJ: Next generation of protein microarray support materials: evaluation for protein and antibody microarray applications. J Chromatogr A 2003, 1009:97-104.
21. Paweletz CP, Charboneau L, Bichsel VE, Simone NL, Chen T, Gillespie JW, Emmert-Buck MR, Roth MJ, Petricoin IE, Liotta LA: Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001, 20:1981-1989.
22. Nishizuka S, Charboneau L, Young L, Major S, Reinhold WC, Waltham M, Kouros-Mehr H, Bussey KJ, Lee, JK, Espina V, Munson, PJ, Petricoin E 3rd, Liotta LA, Weinstein JN: Proteomic profiling of the NCl-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc Natl Acad Sci U S A 2003, 100:14229-14234.
23. Yan F, Sreekumar A, Laxman B, Chinnaiyan AM, Lubman DM, Barder TJ: Protein microarrays using liquid phase fractionation of cell lysates. Proteomics 2003, 3:1228-1235.
24. Zha H, Raffeld M, Charboneau L, Pittaluga S, Kwak LW, Petricoin E 3rd, Liotta LA and Jaffe ES: Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray. Lab Invest 2004, 84:235-244.
25. Madoz-Gurpide, J, Wang, H, Misek, DE, Brichory, F, Hanash SM: Protein based microarrays: a tool for probing the proteome of cancer cells and tissues. Proteomics 2001, 1:1279-1287.
26. Grubb RL, Calvert VS, Wulkuhle JD, Paweletz CP, Linehan WM, Phillips JL, Chuaqui R, Valasco A, Gillespie J, Emmert-Buck M, Liotta LA, Petricoin EF: Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics 2003, 3:2142-2146.
27. Chan SM, Ermann J, Su L, Fathman CG, Utz PJ: Protein microarrays for multiplex analysis of signal transduction pathways. Nat Med 2004, 10:1390-1396.
28. Baggerly K, Mitra R, Grier R, Medhane D, Lozano G, Kapoor M: Comparison of sample-labeling techniques in DNA microarray experiments. Analytica Chimica Acta 2004, 506:117-125.
29. Kapoor M, Hamm R, Yan W, Taya Y, Lozano G: Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. Oncogene 2000, 19: 358-364.
30. Papagrigorakis E, Iliopoulos D, Asimacopoulos PJ, Safi HJ, Weilbaecher DJ, Ghazzaly KG, Nava ML, Gaubatz JW, Morrisett JD: Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm. Clin Genet 1997, 52:262-271.
31. Cushing GL, Gaubatz JW, Nava ML, Burdick BJ, Bocan TM, Guyton, JR, Weilbaecher D, DeBakey ME, Lawrie GM, Morrisett JD: Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 1989, 9:593-603.
32. Gaubatz JW, Chari MV, Nava ML, Guyton JR, Morrisett JD: Isolation and characterization of the two major apoproteins in human lipoprotein [a]. J Lipid Res. 1987, 28:69-79.
33. Gaubatz JW, Heideman C, Gotto Jr AM, Morrisett JD, Dahlen GH: Human plasma lipoprotein [a]. Structural properties. J Biol Chem 1983, 258:4582-4589.
34. Gaubatz JW, Cushing GL, Morrisett JD: Quantitation, isolation, and characterization of human lipoprotein (a). Methods Enzymol 1986, 129:167-186.
35. Gaubatz JW, Hoogeveen RC, Hoffman AS, Ghazzaly KG., Pownall, HJ, Guevara, J Jr, Koschinsky ML, Morrisett JD: Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins. J Lipid Res 2001, 42:2058-2068.
36. Espina V, Mehta AI, Winters ME, Calvert, V, Wulfkuhle, J, Petricoin, EF 3rd, Liotta LA: Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics 2003, 3:2091-2100.
37. Kapoor M, Lozano G: Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc Natl Acad Sci U S A 1998, 95: 2834-2837.